Pauline Wiertsema

In August 2022, I joined the group of John Haanen as a PhD student.

In this lab my research focusses on personalized T-cell therapies using neoantigen-targeting T-cell receptors in melanoma. This research contributes to the development and clinical application of immunotherapies.